The subsequent antigen presentation triggers the activation of Th1 and Th17 cells, leading to the release of pro-inflammatory cytokines (IL-2, TNF-, IFN-, IL-17), which in turn amplify oxidative stress and perpetuate an amplifying loop of inflammation and tissue damage (Kubiak et al
TB-500 is studied primarily for its cellular migration-promoting, stem cell-mobilising, actin-sequestering, and anti-apoptotic properties across wound healing, cardiac, CNS, and musculoskeletal models
The study employed chitosan nanoparticles as carriers for both a chemotherapy compound and AOD 9604 peptide, hypothesizing that AOD 9604 may potentially facilitate the binding of the compound to multiple protein targets within breast cancer cells in laboratory settings
Clinical use: Post-concussion recovery, ADHD support, cognitive enhancement, and mood regulation